AFOLARIN BANJOKO: Open Payments
NPI 1083775779 · HINESVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$461 in 21 payments from 12 companies in 2025. Trend: 2023 $800 · 2024 $274 · 2025 $461
Food & beverage: $461
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $140 |
| Otsuka America Pharmaceutical, Inc. | 3 | $64 |
| Vanda Pharmaceuticals Inc. | 2 | $50 |
| Janssen Pharmaceuticals, Inc | 2 | $37 |
| ABBVIE INC. | 1 | $30 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
| Bausch Health US, LLC | 1 | $22 |
| Alkermes, Inc. | 1 | $22 |
| HARMONY BIOSCIENCES LLC | 1 | $19 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $19 |
Products named: Auvelity, FANAPT, SPRAVATO, VRAYLAR, REXULTI, AUSTEDO XR, APLENZIN, ARISTADA.
Industry payments across GA — which companies pay providers there.
